April 11, 2018
Thomas Gervais in one of the professors from Polytechnique Montréal supported by TransMedTech institute and its partners.
- Firstly, prof. Gervais will work on « Plateforme μFO – microfluidique pour l’oncologie ».
- Secondly on « muFO 2. Spheroid Phenotyping under Radiation (SPHERAD): chip-based treatment response assays for anti-cancer drug discovery and repurposing ».
Both in cancer and biosensor sector, in collaboration with CHUM and Institut du cancer de Montréal.
